CN110892890A - 一种血管的低温保存方法及复温方法 - Google Patents
一种血管的低温保存方法及复温方法 Download PDFInfo
- Publication number
- CN110892890A CN110892890A CN201911318066.4A CN201911318066A CN110892890A CN 110892890 A CN110892890 A CN 110892890A CN 201911318066 A CN201911318066 A CN 201911318066A CN 110892890 A CN110892890 A CN 110892890A
- Authority
- CN
- China
- Prior art keywords
- cryoprotectant
- blood vessel
- rewarming
- soaking
- percent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004204 blood vessel Anatomy 0.000 title claims abstract description 128
- 238000000034 method Methods 0.000 title claims abstract description 46
- 238000004321 preservation Methods 0.000 title abstract description 19
- 239000002577 cryoprotective agent Substances 0.000 claims abstract description 108
- 238000001816 cooling Methods 0.000 claims abstract description 45
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims abstract description 43
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract description 42
- 239000002122 magnetic nanoparticle Substances 0.000 claims abstract description 28
- 239000007788 liquid Substances 0.000 claims abstract description 21
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 21
- 230000002792 vascular Effects 0.000 claims abstract description 20
- 229920001612 Hydroxyethyl starch Polymers 0.000 claims abstract description 19
- 238000005138 cryopreservation Methods 0.000 claims abstract description 19
- 229940050526 hydroxyethylstarch Drugs 0.000 claims abstract description 19
- 239000001963 growth medium Substances 0.000 claims abstract description 18
- 239000004094 surface-active agent Substances 0.000 claims abstract description 10
- 238000007789 sealing Methods 0.000 claims abstract description 4
- 238000002791 soaking Methods 0.000 claims description 21
- 239000012980 RPMI-1640 medium Substances 0.000 claims description 16
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 6
- 238000004140 cleaning Methods 0.000 claims description 6
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical group [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 5
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims description 5
- 239000012091 fetal bovine serum Substances 0.000 claims description 4
- 230000010412 perfusion Effects 0.000 claims description 4
- 238000011010 flushing procedure Methods 0.000 claims description 3
- 239000003973 paint Substances 0.000 claims description 3
- 239000003945 anionic surfactant Substances 0.000 claims description 2
- 239000012894 fetal calf serum Substances 0.000 claims description 2
- 238000007710 freezing Methods 0.000 abstract description 10
- 230000008014 freezing Effects 0.000 abstract description 10
- 230000009467 reduction Effects 0.000 abstract description 5
- 210000001519 tissue Anatomy 0.000 description 28
- 230000008569 process Effects 0.000 description 13
- 230000035882 stress Effects 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 238000004017 vitrification Methods 0.000 description 9
- 239000000463 material Substances 0.000 description 8
- 239000003223 protective agent Substances 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 7
- 210000000056 organ Anatomy 0.000 description 6
- 238000002054 transplantation Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000010186 staining Methods 0.000 description 5
- 210000001644 umbilical artery Anatomy 0.000 description 5
- 102000008186 Collagen Human genes 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 210000004177 elastic tissue Anatomy 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000007490 hematoxylin and eosin (H&E) staining Methods 0.000 description 3
- 230000003204 osmotic effect Effects 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000008646 thermal stress Effects 0.000 description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000002744 extracellular matrix Anatomy 0.000 description 2
- 238000000265 homogenisation Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000002105 nanoparticle Substances 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 206010047115 Vasculitis Diseases 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 239000012237 artificial material Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 210000002390 cell membrane structure Anatomy 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 231100000045 chemical toxicity Toxicity 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000000113 differential scanning calorimetry Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 210000003989 endothelium vascular Anatomy 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N ferrosoferric oxide Chemical compound O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 230000004660 morphological change Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000000162 organ preservation solution Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 208000001297 phlebitis Diseases 0.000 description 1
- 239000003761 preservation solution Substances 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- JZVZOOVZQIIUGY-UHFFFAOYSA-M sodium;tridecanoate Chemical compound [Na+].CCCCCCCCCCCCC([O-])=O JZVZOOVZQIIUGY-UHFFFAOYSA-M 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000009864 tensile test Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000000930 thermomechanical effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 238000007631 vascular surgery Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0221—Freeze-process protecting agents, i.e. substances protecting cells from effects of the physical process, e.g. cryoprotectants, osmolarity regulators like oncotic agents
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0278—Physical preservation processes
- A01N1/0284—Temperature processes, i.e. using a designated change in temperature over time
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0278—Physical preservation processes
- A01N1/0294—Electromagnetic, i.e. using electromagnetic radiation or electromagnetic fields
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Physics & Mathematics (AREA)
- Electromagnetism (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
-1K/min | -1℃/min降到-100℃,投入液氮 |
-2K/min | -2℃/min降到-100℃,投入液氮 |
-5K/min | -5℃/min降到-100℃,投入液氮 |
-10K/min | -10℃/min降到-100℃,投入液氮 |
1-5K/min | -1℃/min降到-40℃,-5℃/min降到-100℃,投入液氮 |
2-5K/min | -2℃/min降到-40℃,-5℃/min降到-100℃,投入液氮 |
1-10K/min | -1℃/min降到-40℃,-10℃/min降到-100℃,投入液氮 |
Claims (10)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911298826X | 2019-12-17 | ||
CN201911298826 | 2019-12-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110892890A true CN110892890A (zh) | 2020-03-20 |
CN110892890B CN110892890B (zh) | 2021-09-17 |
Family
ID=69788985
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911318066.4A Active CN110892890B (zh) | 2019-12-17 | 2019-12-19 | 一种血管的低温保存方法及复温方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110892890B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113575572A (zh) * | 2021-08-19 | 2021-11-02 | 上海理工大学 | 一种血管玻璃化保存的超快速复温方法 |
CN114568424A (zh) * | 2022-02-22 | 2022-06-03 | 尹利民 | 一种脂肪间充质干细胞保存用添加剂及其应用 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1491538A (zh) * | 2003-08-28 | 2004-04-28 | 中国人民解放军第三军医大学 | 一种血管玻璃化保存液及血管保存方法 |
CN101720753A (zh) * | 2009-12-09 | 2010-06-09 | 中国人民解放军第四军医大学 | 组织工程产品的低温保存液及其使用方法 |
CN108244094A (zh) * | 2016-12-28 | 2018-07-06 | 江苏为真生物医药技术股份有限公司 | 血液保存剂及其配套的采血管 |
CN108812643A (zh) * | 2018-07-18 | 2018-11-16 | 银丰生物工程集团有限公司 | 人胎盘绒毛膜组织的制备冻存方法和应用 |
CN108967416A (zh) * | 2017-06-05 | 2018-12-11 | 中国科学院理化技术研究所 | 一种冷冻保护剂及其应用 |
CN109042624A (zh) * | 2018-07-18 | 2018-12-21 | 银丰生物工程集团有限公司 | 人胎盘绒毛膜下大血管组织的制备冻存方法和应用 |
CN109892321A (zh) * | 2019-04-17 | 2019-06-18 | 中国科学技术大学 | 一种大体积生物样本低温保存的方法 |
-
2019
- 2019-12-19 CN CN201911318066.4A patent/CN110892890B/zh active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1491538A (zh) * | 2003-08-28 | 2004-04-28 | 中国人民解放军第三军医大学 | 一种血管玻璃化保存液及血管保存方法 |
CN101720753A (zh) * | 2009-12-09 | 2010-06-09 | 中国人民解放军第四军医大学 | 组织工程产品的低温保存液及其使用方法 |
CN108244094A (zh) * | 2016-12-28 | 2018-07-06 | 江苏为真生物医药技术股份有限公司 | 血液保存剂及其配套的采血管 |
CN108967416A (zh) * | 2017-06-05 | 2018-12-11 | 中国科学院理化技术研究所 | 一种冷冻保护剂及其应用 |
CN108812643A (zh) * | 2018-07-18 | 2018-11-16 | 银丰生物工程集团有限公司 | 人胎盘绒毛膜组织的制备冻存方法和应用 |
CN109042624A (zh) * | 2018-07-18 | 2018-12-21 | 银丰生物工程集团有限公司 | 人胎盘绒毛膜下大血管组织的制备冻存方法和应用 |
CN109892321A (zh) * | 2019-04-17 | 2019-06-18 | 中国科学技术大学 | 一种大体积生物样本低温保存的方法 |
Non-Patent Citations (3)
Title |
---|
冯玉庆,王政禄: "血管移植物的研究及应用进展", 《实用器官移植电子杂志》 * |
邱佳裔等: "细胞、组织冻存方法及应用的研究进展 ", 《中国生物制品学杂志》 * |
鲁元刚等: "人毛乳头细胞的冻存 ", 《重庆大学学报(自然科学版)》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113575572A (zh) * | 2021-08-19 | 2021-11-02 | 上海理工大学 | 一种血管玻璃化保存的超快速复温方法 |
CN114568424A (zh) * | 2022-02-22 | 2022-06-03 | 尹利民 | 一种脂肪间充质干细胞保存用添加剂及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN110892890B (zh) | 2021-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102438445B (zh) | 组织的无冰低温贮藏法 | |
EP0399647B1 (en) | Method of revitalizing cells prior to cryopreservation | |
CN110892890B (zh) | 一种血管的低温保存方法及复温方法 | |
Wang et al. | Cryopreservation of tissue-engineered dermal replacement in Me2SO: Toxicity study and effects of concentration and cooling rates on cell viability | |
US20090258337A1 (en) | Thawed organ or tissue or thawed cell group to be donated, transplanted, added, or administered to living body, production process thereof, supercooled solution therefor, and production apparatus of the organ or tissue | |
JP2013502275A (ja) | 組織の処理方法 | |
JPH09505032A (ja) | 培養組織等価物の凍結保存 | |
CN104145943A (zh) | 一种人脐带华通氏胶组织的冻存保护液及其制备与应用 | |
CN111657267B (zh) | 一种用于软骨,肌腱,半月板保存的无冰晶冷冻保存液和冷冻方法 | |
JP2004537035A (ja) | 組織学的検査及び病理学的検査用の組織の試料を作成する方法及び装置 | |
CN108641999A (zh) | 一种卵巢组织的冻存与复苏方法 | |
CN108812643B (zh) | 人胎盘绒毛膜组织的制备冻存方法和应用 | |
CN109892321A (zh) | 一种大体积生物样本低温保存的方法 | |
CN109699634A (zh) | 一种间充质干细胞的超低温冻存与复苏方法 | |
Prokopyuk et al. | Safety of placental, umbilical cord and fetal membrane explants after cryopreservation | |
CN113261557A (zh) | 一种干细胞冻存液及干细胞冻存方法 | |
CN109497039A (zh) | 脐带组织的冻存复苏方法和间充质干细胞的制备方法 | |
Feng et al. | Evaluation and preservation of vascular architectures in decellularized whole rat kidneys | |
CN109122665A (zh) | 以冻存脐带组织保存多种干细胞的方法、复苏方法及应用 | |
CN113973805A (zh) | 细胞冻存试剂盒及其使用方法 | |
CN108812642B (zh) | 一种依结构层次制备胎盘组织及冻存的系统方法和应用 | |
CN109042624B (zh) | 人胎盘绒毛膜下大血管组织的制备冻存方法和应用 | |
Pan et al. | Prediction of rat liver transplantation outcomes using energy metabolites measured by microdialysis | |
Cao et al. | Improving Mechanical Properties of Vitrified Umbilical Arteries with Magnetic Warming | |
CA2804639C (en) | Pancreatic islet separation method, and protective solution for protecting pancreatic islet tissue |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231128 Address after: 250101 Export Processing Zone, Jinan High-tech Zone, Shandong Province, 1109 Gangxing Third Road Patentee after: YINFENG CRYOGENIC MEDICAL TECHNOLOGY CO.,LTD. Patentee after: Shandong Yinfeng Institute of Life Sciences Patentee after: SHAANXI STEM CELL ENGINEERING Co.,Ltd. Address before: 250101 1109 Gangxing Third Road, export processing zone, high tech Zone, Jinan City, Shandong Province Patentee before: YINFENG CRYOGENIC MEDICAL TECHNOLOGY CO.,LTD. Patentee before: Shandong Yinfeng Institute of Life Sciences |
|
TR01 | Transfer of patent right |